NCT02318875View on ClinicalTrials.gov

Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles Disorders

PHASE3CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Pain
Interventions
DIETARY_SUPPLEMENT

Kritech administration

300mg/day (1 capsule) during 12 weeks; oral ingestion

OTHER

Placebo adminstration

1 placebo capsule per day during 12 weeks; oral ingestion

Trial Locations (1)

33076

Plateforme de Recherche Clinique - CIC1401- Plurithématique Tripode 13A3 Hôpital PELLEGRIN, Bordeaux

All Listed Sponsors
lead

Vivatech

INDUSTRY

NCT02318875 - Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles Disorders | Biotech Hunter | Biotech Hunter